|
|
| | BAY 2666605 Basic information |
| Product Name: | BAY 2666605 | | Synonyms: | BAY 2666605;anticancer effect,inhibit,BAY 2666605,orally active,PDE3A-SLFN12 Complex,Phosphodiesterase (PDE),BAY2666605,BAY-2666605,Inhibitor;2H-1,3,4-Oxadiazin-2-one, 5-[4'-fluoro-2-(trifluoromethyl)[1,1'-biphenyl]-4-yl]-3,6-dihydro-6-methyl-, (6S)-;BAY 266605;(S)-5-[4’-Fluoro-2-(trifluoromethyl)-4-biphenylyl]-6-methyl-3,6-dihydro-2H-1,3,4-oxadiazin-2-one | | CAS: | 2275774-60-0 | | MF: | C17H12F4N2O2 | | MW: | 352.28 | | EINECS: | | | Product Categories: | | | Mol File: | 2275774-60-0.mol |  |
| | BAY 2666605 Chemical Properties |
| density | 1.40±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | pka | 9.07±0.60(Predicted) |
| | BAY 2666605 Usage And Synthesis |
| | BAY 2666605 Preparation Products And Raw materials |
|